Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Accumulated Depreciation & Amortization: 2020-2024

  • Universe Pharmaceuticals' Accumulated Depreciation & Amortization rose 10.15% to $6.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $24.2 million, marking a year-over-year increase of 100.00%. This contributed to the annual value of $6.7 million for FY2024, which is 10.15% up from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Accumulated Depreciation & Amortization of $6.7 million as of Q3 2024, which was up 10.15% from $6.1 million recorded in Q3 2023.
  • In the past 5 years, Universe Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $6.7 million in Q3 2024 and a low of -$4,428.1 billion during Q3 2020.
  • For the 3-year period, Universe Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $6.1 million, with its median value being $6.1 million (2023).
  • In the last 5 years, Universe Pharmaceuticals' Accumulated Depreciation & Amortization skyrocketed by 100.00% in 2021 and then fell by 1.21% in 2022.
  • Over the past 5 years, Universe Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at -$4,428.1 billion in 2020, then soared by 100.00% to $5.8 million in 2021, then declined by 1.21% to $5.7 million in 2022, then grew by 5.96% to $6.1 million in 2023, then rose by 10.15% to $6.7 million in 2024.
  • Its Accumulated Depreciation & Amortization stands at $6.7 million for Q3 2024, versus $6.1 million for Q3 2023 and $5.7 million for Q3 2022.